Delayed Paclitaxel-Trastuzumab-Induced Interstitial Pneumonitis in Breast Cancer

Publisher： Karger

E-ISSN： 1662-6575|4|1|186-191

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.4, Iss.1, 2011-04, pp. : 186-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interstitial Pneumonitis Secondary to Trastuzumab: A Case Report and Literature Review

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-06 ,pp. : 524-530

Karger

Access to resources Recommend Favorite

Weekly Paclitaxel (Taxol®) with or without Trastuzumab (Herceptin®) in Advanced Breast Cancer: A Community-Based Observation Study

By  

Oncology Research and Treatment, Vol. 26, Iss. 2, 2003-05 ,pp. : 128-132

Karger

Access to resources Recommend Favorite

Paclitaxel-Induced Cell-Mediated Hypersensitivity Pneumonitis

By  

Oncology, Vol. 55, Iss. 4, 1998-06 ,pp. : 340-344

Karger

Access to resources Recommend Favorite

An Atypical Case of Fulminant Interstitial Pneumonitis Induced by Carbamazepine

By  

Current Drug Safety, Vol. 4, Iss. 1, 2009-01 ,pp. : 30-33

Bentham Science Publishers

Access to resources Recommend Favorite

Histopathological improvement of scleroderma induced by paclitaxel in a patient with breast cancer

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 12, 2015-12 ,pp. : 1198-1199

John Wiley & Sons Inc

Access to resources Recommend Favorite